This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Obama Health Care Plan Squeezes ETFs

Stocks in this article: IHF UNH HUM

The nightmare scenario for health insurers, a "Medicare for All" system like the one Representative Dennis Kucinich envisioned in his 2005 bill, could put many of these companies out of business. On the other hand, the U.S. automobile industry and other sectors consider the end of company-sponsored health care the route to international competitiveness.

Worst-Performing Healthcare & Biotechnology Funds for the Week Ending Thursday, Feb. 26
Fund (Ticker) Rating
Fund Type
1 Week Total Return
iShares Dow Jones US Healthcare Providers Index Fund (IHF) C-
ETF
-16.31%
ProShares Ultra Health Care (RXL) D+
ETF
-15.83%
Fidelity Select Medical Delivery Portfolio (FSHCX) C+
Open-End
-15.60%
ProFunds Health Care UltraSector ProFund (HCPIX) C+
Open-End
-12.20%
PowerShares Dynamic Healthcare Services Portfolio (PTJ) D-
ETF
-12.01%
PowerShares Dynamic Healthcare Sector Portfolio (PTH) C
ETF
-10.81%
John Hancock Health Sciences Fund (JHGRX) C+
Open-End
-10.53%
ProFunds Pharmaceuticals UltraSector ProFund (PHPIX) B-
Open-End
-10.32%
Hartford Global Health HLS Fund (HIAHX) U
Open-End
-9.39%
Vanguard Health Care Fund (VGHCX) A-
Open-End
-9.02%
Source: Bloomberg & TheStreet.com Ratings

The C-rated ProShares UltraShort Health Care Fund (RXD), which bets on falling stocks, advanced 17%.

Two Rydex ETFs lacked trading activity on Feb. 19, so comparable return data isn't available. But based on the funds' net asset values, the Rydex Inverse 2X S&P Select Sector Health Care ETF (RHO) gained 18%, while the bullish equivalent, Rydex 2X S&P Select Sector Health Care ETF (RHM) lost 17%. These 200% leveraged funds would have been the best- and worst-performing health-care funds last week.

Until the uncertainty surrounding the health-care system is resolved, the outlook for health and biotechnology shares and the funds that hold them remains murky.

For more information, check out an explanation of our ratings.

Kevin Baker became the senior financial analyst for TSC Ratings upon the August 2006 acquisition of Weiss Ratings by TheStreet.com, covering mutual funds. He joined the Weiss Group in 1997 as a banking and brokerage analyst. In 1999, he created the Weiss Group's first ratings to gauge the level of risk in U.S. equities. Baker received a B.S. degree in management from Rensselaer Polytechnic Institute and an M.B.A. with a finance specialization from Nova Southeastern University.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs